Cellular Immunology

Cellular Immunology is a journal on the immune activities of cells, published by Elsevier.《Cellular Immunology》是一份聚焦细胞免疫活动的期刊，由爱思唯尔出版。

It was founded in 1970 and has carried laboratory and clinical work on how cells of the immune system behave.该刊创办于 1970 年，载有关于免疫系统细胞如何活动的实验室与临床工作。

In the 2025 edition of the journal citation report it holds an impact factor of 3.3, and it stands in the third quartile of immunology.在 2025 年版期刊引证报告中，该刊的影响因子为 3.3，在免疫学类目列第三区。

Scope

• The journal publishes original investigations into the immune activities of cells, and it takes work from the experiment and from the clinic alike.该刊发表细胞免疫活动方面的原创研究，兼收来自实验与临床的工作。

• The scope runs across in vitro and in vivo studies of cellular immune responses, and the journal admits work on either side.收稿范围横跨细胞免疫应答的体外与体内研究，该刊两侧兼收。

• Purely clinical descriptive studies are not taken, and the journal asks that a paper reach beyond the description of a case.纯粹临床描述性研究不予收载，该刊要求论文超出对病例的描述。

• Antigen receptor sites are named, and the journal carries work on how a lymphocyte recognises what it is built for.抗原受体部位被点名，该刊刊载淋巴细胞如何识别其识别对象的工作。

• Autoimmunity is treated, and the journal admits work on how the immune system turns against the body's own tissue.自身免疫得到处理，该刊收载免疫系统如何转而攻击自体组织的工作。

• Delayed type hypersensitivity is named, and the journal takes work on the cellular side of such a response.迟发型超敏被点名，该刊收载这类反应中细胞一侧的工作。

• Immunological deficiency and its reconstitution are treated, and the journal carries work on what is missing and how it is restored.免疫缺陷及其重建得到处理，该刊刊载何物缺失、如何被恢复的工作。

• Immune surveillance and tumour immunity are part of the remit, and the journal admits work on how a cell is watched or left alone.免疫监视与肿瘤免疫属于收稿范围，该刊收载细胞如何被监视或被放过的工作。

• Immunomodulation is named, and the journal takes work on how a response is turned up or held back.免疫调节被点名，该刊收载应答如何被增强或抑制的工作。

• Immunotherapy is treated, and the journal carries work that turns a finding about cells toward a treatment.免疫治疗得到处理，该刊刊载把关于细胞的发现带向治疗的工作。

• Lymphokines and cytokines are named, and the journal admits work on the signals that pass between cells.淋巴因子与细胞因子被点名，该刊收载细胞之间传递的信号方面的工作。

• Nonantibody immunity is part of the remit, and the journal takes work on defence that does not run through an antibody.非抗体免疫属于收稿范围，该刊收载不经抗体而行的防御方面的工作。

• Parasite immunology is treated, and the journal carries work on how a cell answers an infestation.寄生虫免疫学得到处理，该刊刊载细胞如何应答寄生物侵扰的工作。

• Resistance to intracellular infection is named, and the journal admits work on how a cell rids itself of a resident microbe.对胞内感染的抵抗力被点名，该刊收载细胞如何清除体内寄居微生物的工作。

• The thymus and lymphocyte immunobiology are treated, and the journal takes work on where a lymphocyte is made and how it matures.胸腺与淋巴细胞免疫生物学得到处理，该刊收载淋巴细胞在何处生成、如何成熟的工作。

• Transplantation immunology is part of the remit, and the journal carries work on how a graft is accepted or refused.移植免疫学属于收稿范围，该刊刊载移植物如何被接受或排斥的工作。

History

• The journal was founded in 1970, and it first appeared from a house in New York under the imprint Academic Press.该刊创办于 1970 年，最初由纽约一家出版社以学术出版社的名义发行。

• Academic Press was later taken into Elsevier, and the title has been issued from Amsterdam since about the turn of the century.学术出版社后来并入爱思唯尔，该刊自世纪之交前后起在阿姆斯特丹发行。

• The pair of numbers has stayed with the title, and the print and electronic editions share the same strings of digits.该对刊号一直伴随题名，印本与电子版共用同样的数字串。

• Two editors led the title for long stretches in its first decades, one from a laboratory in the United States and one later from the same country.在该刊最初的数十年中，先后两位主编长期主持，一位来自美国的实验室，另一位其后亦出自同一国家。

• A new editorial team took office at the start of 2024, and the journal wrote to its readers to mark the change.一支新的编辑团队于 2024 年初就任，该刊致信读者以标记这一变更。

• Twelve issues are gathered into a year in the present arrangement, and the journal keeps a monthly rhythm.按现行安排该刊每年汇集十二期，保持月刊节奏。

• Articles are published continuously as well, so that a paper may appear ahead of the issue it is assigned to.论文亦连续发表，因而一篇论文可以在其所归的某一期之前先行出现。

• The journal is hybrid, and an author may pay a charge to make a paper free to read or leave it behind a subscription.该刊为混合模式，作者可以缴费使论文免费阅读，也可以留其在订阅之后。

• The impact figure has eased in recent editions, standing at 3.7 for 2023 and reaching 3.3 in the 2025 edition.影响因子在近期各版中回落，2023 年为 3.7，2025 年版为 3.3。

• The journal is indexed in the science citation index expanded, and it is carried in MEDLINE and in PubMed.该刊被科学引文索引扩展版收录，并被 MEDLINE 与 PubMed 收录。

• It is also listed in the index medicus and in the usual immunological abstracting services.该刊亦被医学索引以及惯常的免疫学文摘服务收录。

• Special issues are assembled around a theme, and the journal gathers papers on such subjects as the biology of a regulatory cell.该刊围绕主题编成专刊，汇集诸如调节性细胞生物学一类题目的论文。

Editors

• Two editors-in-chief share the office, Simon Fillatreau of Paris Cité University in France and Yi Hao of the Shanghai Public Health Clinical Center in China.两位主编分担此职，即法国巴黎西岱大学的（Simon Fillatreau）与上海市公共卫生临床中心的（Yi Hao）。

• One works on the humoral side of immunity, and the other on B cell homeostasis, autoimmunity and ageing.一位研究免疫的体液一侧，另一位研究 B 细胞稳态、自身免疫与衰老。

• An earlier team took office in 2024, and the journal names a group of executive editors drawn from universities in the United States and beyond.更早的一支团队于 2024 年就任，该刊列出一组来自美国及其他国家大学的执行编辑。

• The board is international in its reach, and the journal lists members from more than a dozen countries.编委会触角遍及国际，该刊列出十数个国家的成员。

• The journal sets out the classes of manuscript it takes, along with the length and structure each of them should follow.该刊列明所收稿件的类别，以及各类别应遵循的篇幅与结构。

• Each paper is sent to independent referees, and the review is anonymous on the side of the reviewer.每篇论文送交独立审稿人，评审在审稿人一侧为匿名。

• Authors must declare any competing interest, and the journal states its ethical requirements in full.作者必须声明任何利益冲突，该刊完整说明其伦理要求。

• Work that involves human or animal subjects is held to the usual standards, and the journal asks that approval be recorded.涉及人或动物的研究须达到惯常标准，该刊要求记录批准情况。

• A paper that rests on a novel reagent is asked to name and characterise it, so that another laboratory can repeat the work.依据新型试剂的研究须指明并表征该试剂，使另一实验室可以重复这项工作。

• Manuscripts are submitted through the publisher's system, and an enquiry may be made before a paper is written.稿件通过出版方的系统投递，在动笔之前可先行询问。

• Data sharing is encouraged, and the journal points to the publisher's policy that governs it.该刊鼓励数据共享，并指明出版方约束此事的政策。

• The journal is read by immunologists and by cell biologists, by clinicians and by pathologists, and it writes for all of them.该刊的读者既有免疫学家与细胞生物学家，也有临床医生与病理学家，它为这几类人写作。

• Work that links a receptor to a disease is given room, and the journal asks what the link promises for treatment.把受体与疾病相连的工作有篇幅可用，该刊追问这一联系对治疗寄予何种希望。

• Studies that report a negative result are taken, since a pathway that proved dispensable is worth recording.报告阴性结果的研究也在收载之列，因为被证明可有可无的通路同样值得记录。

• Work on a regulatory cell appears among the subjects, and the journal carries papers on how a response is held in check.调节性细胞方面的工作列于选题之中，该刊刊载应答如何被约束的论文。

• Work on the maturation of a lymphocyte is treated, and the journal admits papers on how a cell learns to leave its birthplace.淋巴细胞成熟方面的工作得到处理，该刊收载细胞如何学会离开其诞生地的论文。

• The journal keeps its reviews distinct from its original reports, and a reader can tell from the rubric which is which.该刊把综述与原始报告区分开来，读者可从栏目看出何者为何者。

• Work on the signalling between two immune cells is named, and the journal takes papers on what passes and what it changes.两种免疫细胞之间信号传递的工作被点名，该刊收载传递了什么、改变了什么的论文。

• The journal follows the publisher's policy on research integrity, and it records corrections and withdrawals where they arise.该刊遵循出版方的研究诚信政策，出现更正与撤稿时予以记录。